Brief: Allergy Therapeutics Appoints Shaun Furlong As Chief Financial Officer
10/07/2023 13:32
July 10 (Reuters) - Allergy Therapeutics PLC AGY.L :
* ALLERGY THERAPEUTICS - APPOINTMENT OF CHIEF FINANCIAL
OFFICER
* ALLERGY THERAPEUTICS PLC - PROMOTION OF SHAUN FURLONG TO
CHIEF
FINANCIAL OFFICER
* ALLERGY THERAPEUTICS PLC - CURRENT INTERIM CFO, MARTIN
HOPCROFT, WILL LEAVE COMPANY.
Source text for Eikon: ID:nRSJ5339Fa
Further company coverage: AGY.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allergy Therapeutics
See all newsBrief: Allergy Therapeutics Expects FY 2026 Revenue Of £59.90 Million, Up 9% Reported
UK's Allergy Therapeutics FY revenue beats on Grassmuno launch
Allergy Therapeutics - Trading update for the year ended 30 June 2026
Brief: Allergy Therapeutics Appoints Helge Weiner-Trapness As Executive Chairman
Allergy Therapeutics - Appointment of Executive Chairman